Birkett Bernard 4

4 · WEST PHARMACEUTICAL SERVICES INC · Filed Feb 20, 2025

Insider Transaction Report

Form 4
Period: 2025-02-18
Birkett Bernard
Sr VP, Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-18$211.00/sh+779.353$164,4437,668.773 total
  • Award

    Rst. Stock Unit

    2025-02-18+1,7401,740 total
    Exercise: $0.00Common Stock (1,740 underlying)
  • Tax Payment

    Common Stock

    2025-02-18$211.00/sh237.764$50,1687,431.009 total
  • Exercise/Conversion

    Common Stock

    2025-02-18$211.00/sh+124.977$26,3707,555.986 total
  • Tax Payment

    Common Stock

    2025-02-18$211.00/sh35.606$7,5137,520.38 total
  • Award

    Stock Option (Right to Buy)

    2025-02-18+4,0204,020 total
    Exercise: $211.00From: 2026-02-18Exp: 2035-02-18Common Stock (4,020 underlying)
Footnotes (1)
  • [F1]This award vests in four equal installments beginning on February 18, 2026.

Documents

2 files
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY (PUBLIC): POA